Nanoparticles show promise in treatment for triple-negative breast cancer, finds stud

[News]

Approximately 10-20 percent of diagnosed breast cancers are found to be triple-negative, meaning the breast cancer cells test negative for estrogen and progesterone receptors as well as HER2 receptors, genes that can play a role in the development of breast cancer.

More... (https://www.news-medical.net/news/20181001/Nanoparticles-show-promise-in-treatment-for-triple-negative-breast-cancer-finds-study.aspx)